Strategic opportunities in clinical islet transplantation

被引：102

作者：

Shapiro, AMJ ^{[1
]}

Lakey, JRT ^{[1
]}

Paty, BW ^{[1
]}

Senior, PA ^{[1
]}

Bigam, DL ^{[1
]}

Ryan, EA ^{[1
]}

机构：

[1] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB T6G 2C8, Canada

来源：

TRANSPLANTATION | 2005年 / 79卷 / 10期

关键词：

clinical transplantation; islets; immunosuppression (clinical and experimental); immunosuppressive drugs; experimental transplantation;

D O I：

10.1097/01.TP.0000157300.53976.2A

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

More than 471 patients with type 1 diabetes have received islet transplants at 43 institutions worldwide in the past 5 years. High rates of insulin independence have been observed at 1 year in the leading islet transplant centers, and an international multicenter trial has demonstrated reproducible success of the approach. Loss of insulin independence by 5 years in the majority of recipients remains of concern, and immunosuppressant drug side effects necessitate stringent inclusion criteria for islet-alone candidates that have the most severe, unstable glycemic control despite optimal insulin therapy. The advent of new immunosuppressive drugs with superior side-effect profiles (e.g., LEA29Y and FTY720) may open up opportunities for more '' islet- friendly '' approaches. Future opportunities to expand the donor pool using living donor islet transplantation are within reach, and will be enhanced considerably with both donor and recipient adjunctive treatment using islet-specific growth-factors.

引用

页码：1304 / 1307

页数：4

共 32 条

[1] Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates [J].

Adams, AB ;

Shirasugi, N ;

Durham, MM ;

Strobert, E ;

Anderson, D ;

Rees, P ;

Cowan, S ;

Xu, HY ;

Blinder, Y ;

Cheung, M ;

Hollenbaugh, D ;

Kenyon, NS ;

Pearson, TC ;

Larsen, CP .

DIABETES, 2002, 51 (02) :265-270

[2]

Ault A, 2003, LANCET, V361, P2054

[3] Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets [J].

Bell, E ;

Cao, XP ;

Moibi, JA ;

Greene, SR ;

Young, R ;

Trucco, M ;

Gao, ZY ;

Matschinsky, FM ;

Deng, SP ;

Markman, JF ;

Naji, A ;

Wolf, BA .

DIABETES, 2003, 52 (11) :2731-2739

[4] The role of GLP-1 in the regulation of islet cell mass [J].

Bulotta, A ;

Farilla, L ;

Hui, HX ;

Perfetti, R .

CELL BIOCHEMISTRY AND BIOPHYSICS, 2004, :65-77

[5] Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats [J].

Contreras, JL ;

Eckstein, C ;

Smyth, CA ;

Sellers, MT ;

Vilatoba, M ;

Bilbao, G ;

Rahemtulla, FG ;

Young, CJ ;

Thompson, JA ;

Chaudry, IH ;

Eckhoff, DE .

DIABETES, 2003, 52 (12) :2935-2942

[6] Stable α- and β-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates [J].

Contreras, JL ;

Jenkins, S ;

Eckhoff, DE ;

Hubbard, WJ ;

Lobashevsky, A ;

Bilbao, G ;

Thomas, FT ;

Neville, DM ;

Thomas, JM .

AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) :128-138

[7] Diabetes - Islet transplants face test of time [J].

Couzin, J .

SCIENCE, 2004, 306 (5693) :34-37

[8] Enhanced isolated pancreatic islet recovery and functionality in rats by 17β-estradiol treatment of brain death donors [J].

Eckhoff, DE ;

Eckstein, C ;

Smyth, CA ;

Vilatoba, M ;

Bilbao, G ;

Rahemtulla, FG ;

Young, CJ ;

Thompson, JA ;

Chaudry, IH ;

Contreras, JL .

SURGERY, 2004, 136 (02) :336-345

[9] A comparison of media supplement methods for the extended culture of human islet tissue [J].

Fraga, DW ;

Sabek, O ;

Hathaway, DK ;

Gaber, AO .

TRANSPLANTATION, 1998, 65 (08) :1060-1066

[10] Transplantation for type 1 diabetes - Comparison of vascularized whole-organ pancreas with isolated pancreatic islets [J].

Frank, A ;

Deng, SP ;

Huang, XL ;

Velidedeoglu, E ;

Bae, YS ;

Liu, CY ;

Stephenson, R ;

Mohiuddin, M ;

Thambipillai, T ;

Markmann, E ;

Palanjian, M ;

Sellers, M ;

Barker, CF ;

Markmann, JF .

ANNALS OF SURGERY, 2004, 240 (04) :631-640

← 1 2 3 4 →